investigated the neuroprotective potential of L
Diuretics, calcium channel blockers, renin-angiotensin-aldosterone system (RAAS) inhibitors, statins and anticoagulants, as well as modern antidiabetic cardiovascular drugs such as sodium-glucose transport protein 2 (SGLT2) inhibitors, dipeptidyl peptidase 4 (DPP-4) inhibitors and glucagon-like peptide-1 receptor agonists (GLP-1) are used in prevention of CVDs and acute cardiovascular events treatment (Wojtasiska et al., 2023)
If, however, you're designing a study specifically to test the local gut effects of peptides, then an oral formulation might be your test article, but you'd be doing so with the full understanding of its limitations
And I would argue I'd love your opinion on this
*Correspondence: Brittany Johnson, [email protected] Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
